Europe Omega 3 Ingredients for Pharmaceuticals Market - Industry Trends and Forecast to 2027

Report ID: | Publihed: 07-Jan-2020 | No of Pages: 120


USD 3995
USD 5795

Publish Date:


Total pages:


Europe omega-3 ingredients for pharmaceuticals market are projected to register a healthy CAGR of 10.1% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
Europe Omega-3 Ingredients for Pharmaceuticals Market, By Source (Marine and Plant), Type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), Alpha-Linolenic Acid (ALA)), Forms (Liquid and Dry), Therapeutic Areas (Cardiovascular Diseases, Autoimmune Diseases, Bone & Joint Disorders, Neurological Disorders, Ophthalmic Disorders, Skin Health, Cancer, Others), Population Type (Adults and Children), Distribution Channel (Direct and Indirect), Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Sweden, Denmark, Poland, Turkey and Rest of Europe) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of Europe omega-3 ingredients for pharmaceuticals market are:

• Rising demand of functional and supplement food
• Rising burden of lifestyle diseases across globe leads the demand of omega-3 based products

Market Players:

The key market players for Europe omega-3 ingredients for pharmaceuticals market are listed below:

• Novasep
• AbbVie Inc.
• KD Pharma Group
• Corbion NV
• AstraZeneca
• GlaxoSmithKline plc
• Croda International Plc
• ANI Pharmaceuticals, Inc.
• Epax (a subsidiary of Pelagia AS)
• Strides Pharma Science Limited
• Pharma Marine AS
• Solutex

Report Subsumes the following

Competitors Analysis Go To Market Strategies
Regional Coverage with precise Market Numbers Global Impact post Covid-19
Market Penetration Strategies Granular breakdown By Type and By Application.